Its Phase IIb stumble failing to hit the statistical bar for commercial obesity treatment does not erase its promise as a supportive, off-label tool within a carefully managed wellness program
A one-size-fits-all approach to weight loss doesnt work, especially when you are managing chronic conditions like heart disease or clotting disorders
Kushwaha R, Li Y, Makarava N, Pandit NP, Molesworth K, Birukov KG, et al
Severe infections that cause vomiting may impair your ability to maintain the hydration needed during tirzepatide treatment
fMRI reactivity to high-calorie food pictures predicts short- and long-term outcome in a weight-loss program
These thresholds serve as the baseline for clinical decision-making: Obesity: Body Mass Index (BMI) 30 kg/m Overweight with Comorbidity: BMI 27 kg/m accompanied by at least one weight-related condition, such as: Hypertension Dyslipidemia Type 2 Diabetes (T2D) Obstructive Sleep Apnea (OSA) Insight: These thresholds are not merely entry requirements but indicators of metabolic risk